Patients with non-small cell lung cancer (whose cancer cells have low levels of—an abnormal number of chromosomes—tend to respond better to immune checkpoint inhibitor drugs than patients with higher levels, Dana-Farber Cancer Institute researchers found.
Elizabeth Comen originally set out to write a book about the wellness industry, but ended up writing a different book altogether.
